---
title: "City Therapeutics falls 7%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303797442.md"
description: "City Therapeutics fell 7.41% to US$20.50. Down 8.48% over ten sessions and up 13.89% from IPO price."
datetime: "2026-10-30T19:45:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303797442.md)
  - [en](https://longbridge.com/en/news/303797442.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303797442.md)
generator: "portal-rs"
---

# City Therapeutics falls 7%

City Therapeutics (CTY.US) fell more than 7% during regular trading to $20.50.

The stock is down 8.48% over the past ten sessions and up 13.89% from its IPO price.

The Nasdaq Composite is down 2.35% over the past five sessions and up 9.05% year to date.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [CTY.US](https://longbridge.com/en/quote/CTY.US.md)

## Related News & Research

- [BUZZ-Street View: Nvidia's AI story intact despite uncertainty at top](https://longbridge.com/en/news/305945171.md)
- [INSTANT VIEW-Nvidia earnings beat estimates; attention turns to call](https://longbridge.com/en/news/305875718.md)
- [Marvell outlines custom HBM design approach at 2026 OCP Global Summit](https://longbridge.com/en/news/305857411.md)
- [BREAKINGVIEWS-Nvidia leaves the AI trade hanging in purgatory](https://longbridge.com/en/news/305968268.md)
- [Will Upper Stage Recovery Change SpaceX's (SPCX) Narrative](https://longbridge.com/en/news/305914563.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**